Unit 4: Stability, Chromatography & Export Registration

March 16, 2026

Semester 8
BP806T

Stability, Chromatography & Export Registration

How does a manufacturer guarantee that an herbal tablet maintains its exact medicinal potency for three years on a pharmacy shelf? This critical unit details the intensely complex Stability Testing required for heavily fluctuating botanical extracts. Furthermore, you will master the absolutely essential chromatographic techniques (TLC, HPTLC, HPLC) used to instantly ‘fingerprint’ and standardize formulations, and review the rigorous legal paperwork (NDA, Export Dossiers) required to launch them.

Syllabus & Topics

  • 1Stability Testing of Herbal Medicines: Purpose: Determining the exact shelf-life of an herbal product heavily exposed to varying temperatures, extreme humidity, and intense light over time. The Challenge: Active botanical constituents rapidly degrade via oxidation, hydrolysis, and microbial attack. Protocols: Following strictly adapted ICH Q1 guidelines. Accelerated Stability: Subjecting the extract to brutal conditions (40°C / 75% Relative Humidity) for 6 months to mathematically predict its lifespan. Real-time Stability: Storing the drug at standard warehouse conditions (30°C / 65% RH) and checking its chemical fingerprint every 3, 6, 9, 12, 18, 24, and 36 months.
  • 2Application of Chromatographic Techniques in Standardization: Standardization requires identifying and quantifying ‘Chemical Markers’ within a chaotic mixture of 500 compounds. TLC (Thin Layer Chromatography): A rapid, cheap, initial qualitative test to identify the sheer presence of an alkaloid or glycoside. HPTLC (High-Performance TLC): The absolute global gold standard for herbals. Generates highly reproducible, visual ‘fingerprint’ bands of the extract. Heavily used to detect sophisticated adulteration. HPLC (High-Performance Liquid Chromatography): Employs immense pressure to meticulously quantify exactly how many milligrams of an active marker (e.g., curcumin) exist in one gram of extract. GC (Gas Chromatography): Exclusively utilized for highly volatile, essential fragrant oils strictly isolated from the plant.
  • 3Preparation of Documents for New Drug Application (NDA) & Export Registration: NDA Dossier: Compiling massive amounts of highly organized scientific data (Raw material QC, Manufacturing BMRs, Stability data, Pre-clinical Toxicology, and Phase 3 Clinical Trial data) to legally convince the government to approve a completely ‘new’ phytopharmaceutical. Export Registration: Navigating drastically different, frequently contradictory regulatory demands from various importing countries. Often requires immense re-formatting of the entire dossier into an electronic Common Technical Document (eCTD) to satisfy foreign Drug Master Files (DMF).
  • 4GMP Requirements and Drugs & Cosmetics Act Provisions: The strict legal backbone in India. The Drugs and Cosmetics Act (1940) and its Rules heavily regulate the massive, fragmented Ayurvedic, Siddha, and Unani (ASU) pharmaceutical sector. Schedule T specifically outlines the entirely unique, legally mandated GMP requirements regarding factory design, raw material segregation, completely sanitary manufacturing processes, and exhaustive quality control testing exclusively for traditional Indian medicine factories to prevent highly toxic contamination.

Learning Objectives

Predict Shelf-Life: Understand the exact scientific rationale and specific temperature/humidity parameters used in ‘Accelerated’ stability testing for herbal extracts under adapted ICH guidelines.
Select Chromatographic Tools: Justify why a highly sensitive HPTLC ‘fingerprint’ is vastly preferred over a simple chemical color test when attempting to definitively authenticate a massively expensive batch of imported ginseng root.
Compile an NDA: Describe the critical scientific and clinical sections must be heavily documented when filing a New Drug Application for a highly concentrated botanical extract.
Navigate Export Dossiers: Differentiate the immense pre-market regulatory challenges of explicitly launching a ‘new’ medicinal phytopharmaceutical versus simply exporting a ‘traditional dietary supplement’.
Comply with Indian Law: Outline the specific infrastructural and operational factory requirements heavily mandated by ‘Schedule T’ of the Drugs and Cosmetics Act for Ayurvedic manufacturers.

Exam Prep Questions

Q1. Why is an “HPTLC Fingerprint” considered the gold standard for standardizing herbal medicines?

Medicinal plants contain hundreds of naturally occurring chemical compounds, many of which vary depending on environmental conditions such as climate, soil, and harvest time. Measuring every compound individually is impractical.

High Performance Thin Layer Chromatography (HPTLC) provides a solution by separating the plant extract into a distinct pattern of colored or fluorescent bands based on chemical properties such as polarity. This pattern forms a unique “fingerprint” characteristic of a specific plant species.

By comparing the fingerprint pattern of a sample with that of an authentic reference sample, scientists can verify identity, detect adulteration, and ensure consistency of herbal medicines.

Q2. How does a scientist determine that an herbal drug fails an accelerated stability test?

Accelerated stability testing exposes the herbal formulation to stress conditions, commonly 40°C temperature and 75% relative humidity, to simulate long-term storage in a short time.

During this testing period, the product is regularly analyzed—often using techniques like HPLC—to monitor the stability of marker compounds and observe physical changes. A product may fail the test if:

  • The concentration of a key chemical marker decreases beyond acceptable limits (often more than about 5% degradation).

  • Significant physical or microbiological changes occur, such as discoloration, fermentation in liquid formulations, tablet softening, or microbial growth.

If failure occurs, the manufacturer must modify the formulation, improve packaging, or change storage conditions to ensure product stability.

Q3. What makes “Schedule T” different from standard pharmaceutical GMP regulations?

Schedule T of the Drugs and Cosmetics Rules provides Good Manufacturing Practices specifically for Ayurvedic, Siddha, and Unani (ASU) medicines. These products use raw herbal or mineral materials that require different handling compared with conventional pharmaceutical drugs.

While standard pharmaceutical GMP (such as Schedule M) focuses on manufacturing synthetic or chemically defined medicines, Schedule T addresses challenges unique to traditional medicines, including:

  • Proper storage and handling of herbal raw materials

  • Prevention of contamination from dust, insects, and rodents

  • Separate processing areas for traditional preparation methods

  • Quality control measures for herbal and mineral ingredients

These guidelines help ensure that traditional medicines are produced with consistent quality, hygiene, and safety standards.